期刊： CELL REPORTS MEDICINE, 2022; 3 (4)
While immunopathology has been widely studied in patients with severe COVID-19, immune responses in non-hospitalized patients have remained largely el......
期刊： CELL REPORTS MEDICINE, 2022; 3 (7)
This is a phase Ib study of anlotinib plus a programmed death-ligand 1 (PD-L1) inhibitor TQB2450 for plat-inum-resistant or-refractory ovarian cancer.......
期刊： CELL REPORTS MEDICINE, 2022; 3 (8)
Understanding who is at risk of progression to severe coronavirus disease 2019 (COVID-19) is key to clinical decision making and effective treatment. ......
期刊： CELL REPORTS MEDICINE, 2022; 3 (10)
Effective drugs for atrial fibrillation (AF) are lacking, resulting in significant morbidity and mortality. This study demonstrates that network proxi......
期刊： CELL REPORTS MEDICINE, 2022; 3 (11)
We present a deep proteogenomic profiling study of 87 lung adenocarcinoma (LUAD) tumors from the United States, integrating whole-genome sequencing, t......
期刊： CELL REPORTS MEDICINE, 2022; 3 (12)
Voice-based AI-powered digital assistants, such as Alexa, Siri, and Google Assistant, present an exciting op-portunity to translate healthcare from th......
期刊： CELL REPORTS MEDICINE, 2022; 3 (12)
Host-response profiles can discriminate different infections. A new 8-gene blood RNA signature to discriminate bacterial and viral infections extends ......
期刊： CELL REPORTS MEDICINE, 2022; 3 (1)
Visceral leishmaniasis (VL) has emerged as a clinically important opportunistic infection in HIV patients, as VL/HIV co-infected patients suffer from ......
期刊： CELL REPORTS MEDICINE, 2022; 3 (5)
Two doses of Pfizer/BioNTech BNT162b2 mRNA vaccine elicit robust severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibodies ......
期刊： CELL REPORTS MEDICINE, 2022; 3 (10)
Mechanisms of neutrophil involvement in severe coronavirus disease 2019 (COVID-19) remain incompletely understood. Here, we collect longitudinal blood......
期刊： CELL REPORTS MEDICINE, 2022; 3 (11)
An increasing number of breast cancer patients develop brain metastases (BM). Standard-of-care treatments are largely inefficient, and breast cancer b......
期刊： CELL REPORTS MEDICINE, 2022; 3 (11)
The state of immune activation may guide targeted immunotherapy in sepsis. In a double-blind, double-dummy randomized clinical study, 240 patients wit......
